Insights

Sustainable Innovation Evolva's focus on applying fermentation technology to develop natural, high-quality ingredients positions the company to capitalize on the growing consumer demand for sustainable and natural health products, creating opportunities to expand into health, wellness, and sensory markets.

Expanding Market Reach The recent launch of Veri-teTM Resveratrol for pet supplements and partnerships like the one with Grace Breeding demonstrate potential growth channels in the pet care and agricultural sectors, highlighting opportunities to develop targeted ingredient solutions for these expanding markets.

Acquisition & Partnerships Recent asset sales and collaborations suggest a strategic shift that could open avenues for joint ventures and licensing opportunities, facilitating access to new customer bases and distribution networks in biotech, food, and agriculture industries.

Technology-Driven Solutions Evolva's utilization of proprietary technologies such as LipiSperse and its innovation in bio-formulations provide a platform for selling specialty ingredients and advanced biotech solutions to companies seeking sustainable alternatives to chemical products.

Financial & Market Position With revenue in the multimillion dollar range and recent grants supporting R&D, Evolva is well-positioned to partner with investors and corporate clients looking for innovative, nature-based biotech ingredients that address market trends in health, sustainability, and consumer safety.

Evolva Biotech A/S Tech Stack

Evolva Biotech A/S uses 8 technology products and services including oEmbed, Twemoji, JSON-LD, and more. Explore Evolva Biotech A/S's tech stack below.

  • oEmbed
    Dev Tools
  • Twemoji
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Google Analytics
    Web Analytics
  • Nginx
    Web Servers
  • AddThis
    Widgets
  • Facebook
    Widgets

Media & News

Evolva Biotech A/S's Email Address Formats

Evolva Biotech A/S uses at least 1 format(s):
Evolva Biotech A/S Email FormatsExamplePercentage
FirstL@evolva.comJohnD@evolva.com
86%
FirstLast@evolva.comJohnDoe@evolva.com
6%
FirstML@evolva.comJohnMD@evolva.com
5%
FirstLa@evolva.comJohnDo@evolva.com
3%

Frequently Asked Questions

What is Evolva Biotech A/S's phone number?

Minus sign iconPlus sign icon
You can contact Evolva Biotech A/S's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Evolva Biotech A/S's stock symbol?

Minus sign iconPlus sign icon
Evolva Biotech A/S is a publicly traded company; the company's stock symbol is ELVAY.

What is Evolva Biotech A/S's official website and social media links?

Minus sign iconPlus sign icon
Evolva Biotech A/S's official website is evolva.com and has social profiles on LinkedInCrunchbase.

What is Evolva Biotech A/S's SIC code NAICS code?

Minus sign iconPlus sign icon
Evolva Biotech A/S's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evolva Biotech A/S have currently?

Minus sign iconPlus sign icon
As of February 2026, Evolva Biotech A/S has approximately 73 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Cmo: N. B.Vice President Regulatory Affairs: J. M.Head Of Business Finance: M. H.. Explore Evolva Biotech A/S's employee directory with LeadIQ.

What industry does Evolva Biotech A/S belong to?

Minus sign iconPlus sign icon
Evolva Biotech A/S operates in the Biotechnology Research industry.

What technology does Evolva Biotech A/S use?

Minus sign iconPlus sign icon
Evolva Biotech A/S's tech stack includes oEmbedTwemojiJSON-LDjQueryGoogle AnalyticsNginxAddThisFacebook.

What is Evolva Biotech A/S's email format?

Minus sign iconPlus sign icon
Evolva Biotech A/S's email format typically follows the pattern of FirstL@evolva.com. Find more Evolva Biotech A/S email formats with LeadIQ.

How much funding has Evolva Biotech A/S raised to date?

Minus sign iconPlus sign icon
As of February 2026, Evolva Biotech A/S has raised $540K in funding. The last funding round occurred on Oct 21, 2022 for $540K.

Evolva Biotech A/S

Biotechnology ResearchBasel-landschaft, Switzerland51-200 Employees

At Evolva we believe in applying technology platforms, such as fermentation, to help resolve sourcing bottlenecks in nature. These enable us to provide products that can contribute to health, wellbeing and sensory enjoyment. We research, develop and commercialize high quality, affordable, ready-to-formulate ingredients that are based on nature and are available at all times, in any quantity. With around 55 employees from 15 nationalities we promote an interdisciplinary and inclusive working environment.

Section iconCompany Overview

Phone number
Website
evolva.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ELVAY
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $540K

    Evolva Biotech A/S has raised a total of $540K of funding over 10 rounds. Their latest funding round was raised on Oct 21, 2022 in the amount of $540K.

  • $1M$10M

    Evolva Biotech A/S's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $540K

    Evolva Biotech A/S has raised a total of $540K of funding over 10 rounds. Their latest funding round was raised on Oct 21, 2022 in the amount of $540K.

  • $1M$10M

    Evolva Biotech A/S's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.